Copyright
©The Author(s) 2021.
World J Clin Cases. Jul 6, 2021; 9(19): 5266-5269
Published online Jul 6, 2021. doi: 10.12998/wjcc.v9.i19.5266
Published online Jul 6, 2021. doi: 10.12998/wjcc.v9.i19.5266
Figure 1 Time-course of CD4+ T cells, lymphocyte count, alanine aminotransferase, aspartate transaminase, and hepatitis B virus DNA.
A: CD4+ T cells, lymphocyte count, and hepatitis B virus (HBV) DNA; B: Alanine aminotransferase, aspartate transaminase, and HBV DNA. ALT: Alanine aminotransferase; AST: Aspartate transaminase; HBV: Hepatitis B virus.
- Citation: Wu YF, Yu WJ, Jiang YH, Chen Y, Zhang B, Zhen RB, Zhang JT, Wang YP, Li Q, Xu F, Shi YJ, Li XP. COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report. World J Clin Cases 2021; 9(19): 5266-5269
- URL: https://www.wjgnet.com/2307-8960/full/v9/i19/5266.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i19.5266